다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
MiNK Therapeutics Inc (INKT)
MiNK Therapeutics Inc (INKT) 뉴스

INKT

MiNK Therapeutics (INKT)

MiNK Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:INKT

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:33	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/22	20:30	GlobeNewswire Inc.	MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/16	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/14	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/14	20:30	GlobeNewswire Inc.	MiNK Reports First Quarter 2024 Results	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/14	20:28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INKT	MiNK Therapeutics Inc
2024/05/13	20:30	GlobeNewswire Inc.	MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer	NASDAQ:INKT	MiNK Therapeutics Inc
2024/04/30	20:30	GlobeNewswire Inc.	MiNK to Provide Corporate Update and First Quarter 2024 Financial Report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/04/09	01:00	GlobeNewswire Inc.	MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR	NASDAQ:INKT	MiNK Therapeutics Inc
2024/03/21	20:26	IH Market News	U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines	NASDAQ:INKT	MiNK Therapeutics Inc
2024/03/21	20:00	GlobeNewswire Inc.	MiNK Reports Fourth Quarter and Year-End 2023 Results	NASDAQ:INKT	MiNK Therapeutics Inc
2024/03/07	21:30	GlobeNewswire Inc.	MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/03/06	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INKT	MiNK Therapeutics Inc
2024/03/01	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/02/14	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2024/02/14	22:00	GlobeNewswire Inc.	First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab	NASDAQ:INKT	MiNK Therapeutics Inc
2024/02/06	22:00	GlobeNewswire Inc.	MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications	NASDAQ:INKT	MiNK Therapeutics Inc
2024/01/30	22:00	GlobeNewswire Inc.	MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene	NASDAQ:INKT	MiNK Therapeutics Inc
2024/01/19	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INKT	MiNK Therapeutics Inc
2023/12/20	21:30	GlobeNewswire Inc.	ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development	NASDAQ:INKT	MiNK Therapeutics Inc
2023/12/06	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INKT	MiNK Therapeutics Inc
2023/11/09	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2023/11/09	21:00	GlobeNewswire Inc.	MiNK Therapeutics Reports Third Quarter 2023 Results	NASDAQ:INKT	MiNK Therapeutics Inc
2023/11/04	01:00	GlobeNewswire Inc.	MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023	NASDAQ:INKT	MiNK Therapeutics Inc
2023/10/30	21:00	GlobeNewswire Inc.	MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update	NASDAQ:INKT	MiNK Therapeutics Inc
2023/10/18	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INKT	MiNK Therapeutics Inc
2023/09/27	22:05	GlobeNewswire Inc.	MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023	NASDAQ:INKT	MiNK Therapeutics Inc
2023/09/07	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INKT	MiNK Therapeutics Inc
2023/09/07	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INKT	MiNK Therapeutics Inc
2023/08/24	21:30	GlobeNewswire Inc.	MiNK Therapeutics to Participate in September Investor Conferences	NASDAQ:INKT	MiNK Therapeutics Inc

검색 관련기사 보기:NASDAQ:INKT

1 2 3 4 5 다음 >>

Kfw Green Bond Tf 0,01% ...

Montanaro Uk Smaller Com...

Ifc Tf 11% Lg24 Huf

Eternal Rock Token

InternetExchangeToken

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관